The utility of human epididymal protein 4, cancer antigen 125, and risk for malignancy algorithm in ovarian cancer and endometriosis

International Journal of Gynecological Cancer

Volumn 22, Issue 2, 2012, Pages 238-244

  Kadija, Sasa ^a,b   Stefanovic, Aleksandar ^a,b   Jeremic, Katarina ^a,b   Radojevic, Milos M ^a   Nikolic, Ljubinka ^b   Markovic, Ivanka ^a   Atanackovic, Jasmina ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Clinical Center of Serbia   (Serbia)

Author keywords

CA125; Endometriosis; Human epididymis protein 4; Ovarian cancer; ROMA

Indexed keywords

BIOLOGICAL MARKER; CA 125 ANTIGEN; HUMAN EPIDIDYMIS PROTEIN 4;

ALGORITHM; ARTICLE; CANCER RISK; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOMETRIOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MENSTRUATION; OVARY CANCER; OVARY CARCINOMA; OVARY DISEASE; PELVIS; PELVIS SURGERY; PREMENOPAUSE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ALGORITHMS; CA-125 ANTIGEN; CARCINOMA, ENDOMETRIOID; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; CYSTADENOCARCINOMA, SEROUS; ENDOMETRIOSIS; EPIDIDYMAL SECRETORY PROTEINS; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84858062503     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e318234f852     Document Type: Article

References (22)

1. Heintz AP, Odicino F, Maisonneuve P, et al. Carcinoma of the ovary. FIGO 6th Annual Report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006;95:S161-S192.
2. Earle CC, Schrag D, Neville BA, et al. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst. 2006;98:172-180. (Pubitemid 43205479)
3. Vernooij F, Heintz AP, Witteveen PO, et al. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study [published online ahead of print March 11, 2008]. J Natl Cancer Inst. 2008;100:399-406. (Pubitemid 351480512)
4. Paulsen T, Kjaerheim K, Kaern J, et al. Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals. Int J Gynecol Cancer. 2006;:11-17.
5. Moore RG, Maclaughlan S. Current clinical use of biomarkers for epithelial ovarian cancer. Curr Opin Oncol. 2010;22:492-497.
6. Malkasian GD Jr, Knapp RC, Lavin PT, et al. Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease. Am J Obstet Gynecol. 1988;159:341-346.
7. Hellstrom I, Heagerty PJ, Swisher EM, et al. Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms [published online ahead of print April 8, 2010]. Cancer Lett. 2010;296:43-48.
8. Yurkovetsky Z, Skates S, Lomakin A, et al. Development of a multimarker assay for early detection of ovarian cancer [published online ahead of print April 5, 2010]. J Clin Oncol. 2010;28:2159-2166.
9. Nolen B, Velikokhatnaya L, Marrangoni A, et al. Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass [published online ahead of print March 24, 2010]. Gynecol Oncol. 2010;117:440-445.
10. Kirchhoff C, Habben I, Ivell R, et al. A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors. Biol Reprod. 1991;45:350-357.
11. Bouchard D, Morisset D, Bourbonnais Y, et al. Proteins with whey-acidic-protein motifs and cancer. Lancet Oncol. 2006;7:167-174. (Pubitemid 43159503)
12. Galgano MT, Hampton GM, Frierson HF Jr. Comprehensive analysis of HE4 expression in normal and malignant human tissues. Mod Pathol. 2006;19:847-853. (Pubitemid 43780455)
13. Drapkin R, von Horsten HH, Lin Y, et al. Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res. 2005;65:2162-2169. (Pubitemid 40490123)
14. Anastasi E, Marchei GG, Viggiani V, et al. HE4: a new potential early biomarker for the recurrence of ovarian cancer [published online ahead of print January 23, 2010]. Tumour Biol. 2010;31:113-119.
15. Moore RG, McMeekin DS, Brown AK, et al. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass [published online ahead of print October 12, 2008]. Gynecol Oncol. 2009;112:40-46.
16. Moore RG, Jabre-Raughley M, Brown AK, et al. Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass [published online ahead of print May 14, 2010]. Am J Obstet Gynecol. 2010;203:228.e1-228.e6.
17. Moore RG, Brown AK, Miller MC, et al. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass [published online ahead of print December 3, 2007]. Gynecol Oncol. 2008;108:402-408. (Pubitemid 351174295)
18. Van Gorp T, Cadron I, Vergote I. The utility of proteomics in gynecologic cancers. Curr Opin Obstet Gynecol. 2011;23:3-7.
19. Van Gorp T, Cadron I, Despierre E, et al. HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm [published online ahead of print February 8, 2011]. Br J Cancer. 2011;104:863-870.
20. Montagnana M, Lippi G, Ruzzenente O, et al. The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass. J Clin Lab Anal. 2009;23:331-335.
21. Montagnana M, Danese E, Ruzzenente O, et al. The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful? [published online ahead of print February 3, 2011]. Clin Chem Lab Med. 2011;49:521-525.
22. Huhtinen K, Suvitie P, Hiissa J, et al. Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts [published online ahead of print March 31, 2009]. Br J Cancer. 2009;100:1315-1319.